Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility, Safety, and Efficacy of a Metabolic Therapy Program in Conjunction With Standard Treatment for Glioblastoma

NCT04730869 is registered in ClinicalTrials.gov with Waikato Hospital as lead sponsor.

NCT NCT04730869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04730869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility, Safety, and Efficacy of a Metabolic Therapy Program in Conjunction With Standard Treatment for Glioblastoma
Lead sponsor
Waikato Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 26, 2021
Completion date
April 1, 2026
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma